C12Y 304/2404
Serralysin
Official title: Serralysin (3.4.24.40)
C12Y304/2404 (Serralysin) appears on 8 US grants and 21 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 21
- Assignees
- 10
- Inventors
- 33
- Latest grant
- 15 Nov 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 3 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 3 |
| 2020 | 1 | 2 |
| 2021 | 0 | 3 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Truncated and modified serratiopeptidase and polynucleotides encoding the same15 Nov 2022US 11,499,145 B2
- Alkaline protease variant21 Jul 2020US 10,717,949 B2Kao Corporation
- Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof1 Jan 2019US 10,166,275 B2Willingsford Limited
- Method of treating fibrosis in skeletal muscle tissue27 Feb 2018US 9,901,626 B2
- Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof12 Sep 2017US 9,757,436 B2Willingsford Limited
- Methods for expression of fusion-free bovine ultralong cdr3 scaffold16 Jul 2026US 2026/0201020 A1Pelican Technology Holdings, Inc.
- Recombinant production of a collagen peptide preparation and use thereof31 Oct 2024US 2024/0360490 A1
- Fibrinolytic enzyme composition for fibrosis treatment9 Nov 2023US 2023/0355726 A1Advanced Enzyme Technologies Ltd.
- Combination therapy containing immune boosters, digestive enzymes and interferons for cancer treatment25 Nov 2021US 2021/0361671 A1
- Pharmaceutical composition and method of treatment using serratiopeptidase, mannose or its derivative, and optionally antinfection agents2 Sep 2021US 2021/0268075 A1
Most cited
By later US patents
- Preventive and treating agent for blood lipids abnormality and/or arteriosclerosis4US 4,440,749 AKaken Pharmaceutical Co., Ltd. · 1984
- Cellular enhancements in biological systems through the use of li-pofullerene and peptide group combinations2US 9,308,243 B2LivePet, LLC · 2016
- Method of treating fibrosis in skeletal muscle tissue2US 9,901,626 B22018
- Alkaline protease variant1US 10,717,949 B2Kao Corporation · 2020